TYRA

7.96

5.43% 0.41

Handel nachbörslich: 7.94 -0.02 -0.25%

Tyra Biosciences Inc (TYRA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$7.55

Offen:

$7.62

24-Stunden-Volumen:

216.51K

Relative Volume:

0.69

Marktkapitalisierung:

$400.83M

Einnahmen:

Nettoeinkommen (Verlust:

$-83.74M

KGV:

-4.9441

EPS:

-1.61

Netto-Cashflow:

$-64.98M

1W Leistung:

+2.84%

1M Leistung:

-26.84%

6M Leistung:

-63.72%

1J Leistung:

-47.18%

1-Tages-Spanne:

$7.52

$8.02

1-Wochen-Bereich:

$6.42

$8.11

52-Wochen-Spanne:

$6.42

$29.60

Tyra Biosciences Inc Stock (TYRA) Company Profile

Firmenname

Tyra Biosciences Inc

Sektor

Healthcare (1156)

Branche

Biotechnology (678)

Telefon

(619) 728-4760

Adresse

2656 STATE STREET, CARLSBAD

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-26

Neueste SEC-Einreichungen

TYRA's Discussions on Twitter

Vergleichen Sie TYRA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TYRA Tyra Biosciences Inc	7.96	400.83M	0	-83.74M	-64.98M	-1.61
VRTX Vertex Pharmaceuticals Inc	484.22	122.24B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	554.18	59.73B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	580.94	35.43B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	237.77	30.77B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	96.52	23.20B	3.30B	-501.07M	1.03B	-2.1146

Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-07	Eingeleitet	UBS	Buy
2024-10-18	Hochstufung	BofA Securities	Neutral → Buy
2024-08-15	Eingeleitet	Piper Sandler	Overweight
2023-12-15	Herabstufung	BofA Securities	Buy → Neutral
2023-06-30	Eingeleitet	Wedbush	Outperform
2023-02-03	Eingeleitet	Oppenheimer	Outperform
2022-06-23	Eingeleitet	H.C. Wainwright	Buy
2022-03-08	Hochstufung	Jefferies	Hold → Buy
2021-11-08	Herabstufung	Jefferies	Buy → Hold
2021-10-11	Eingeleitet	BofA Securities	Buy
2021-10-11	Eingeleitet	Cowen	Outperform
2021-10-11	Eingeleitet	Jefferies	Buy

Alle ansehen

Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten

Apr 08, 2025

TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm! - ACCESS Newswire

Apr 08, 2025

Apr 07, 2025

Advanced Urothelial Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com

Apr 07, 2025

Apr 06, 2025

Raymond James Financial Inc. Invests $761,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 06, 2025

Apr 04, 2025

HC Wainwright Predicts Reduced Earnings for Tyra Biosciences - Defense World

Apr 04, 2025

Apr 03, 2025

Tyra Biosciences stock hits 52-week low at $8.14 - Investing.com Australia

Apr 03, 2025

Tyra Biosciences stock hits 52-week low at $8.14 By Investing.com - Investing.com South Africa

Apr 03, 2025

(TYRA) Technical Data - news.stocktradersdaily.com

Apr 03, 2025

Apr 01, 2025

Tyra Biosciences (NASDAQ:TYRA) Given Buy Rating at HC Wainwright - Defense World

Apr 01, 2025

Mar 31, 2025

H.C. Wainwright maintains $30 target on Tyra Biosciences stock By Investing.com - Investing.com Canada

Mar 31, 2025

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by Swiss National Bank - Defense World

Mar 31, 2025

What is Wedbush’s Estimate for TYRA FY2029 Earnings? - Defense World

Mar 31, 2025

Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights - Citizen Tribune

Mar 31, 2025

Mar 30, 2025

Wedbush Reiterates “Outperform” Rating for Tyra Biosciences (NASDAQ:TYRA) - Defense World

Mar 30, 2025

Mar 29, 2025

Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth - Yahoo Finance

Mar 29, 2025

Charles Schwab Investment Management Inc. Trims Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Mar 29, 2025

Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up After Better-Than-Expected Earnings - Defense World

Mar 29, 2025

Mar 28, 2025

Tyra Biosciences Advances Precision Medicine Pipeline - TipRanks

Mar 28, 2025

Mar 27, 2025

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by Bank of New York Mellon Corp - Defense World

Mar 27, 2025

Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges By Investing.com - Investing.com South Africa

Mar 27, 2025

Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges - Investing.com

Mar 27, 2025

Mar 26, 2025

Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus Target Price from Analysts - Defense World

Mar 26, 2025

Mar 23, 2025

Trend Tracker for (TYRA) - news.stocktradersdaily.com

Mar 23, 2025

Mar 21, 2025

Victory Capital Management Inc. Purchases 26,560 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Mar 21, 2025

Mar 20, 2025

Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthc - GuruFocus.com

Mar 20, 2025

Mar 19, 2025

US Bancorp DE Purchases Shares of 3,612 Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Mar 19, 2025

Mar 17, 2025

Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga India

Mar 17, 2025

Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - NewsBreak: Local News & Alerts

Mar 17, 2025

Mar 16, 2025

Tyra Biosciences (NASDAQ:TYRA) Sees Large Volume Increase – Should You Buy? - Defense World

Mar 16, 2025

Mar 14, 2025

Tyra Biosciences Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

Mar 14, 2025

Mar 13, 2025

(TYRA) On The My Stocks Page - Stock Traders Daily

Mar 13, 2025

Mar 11, 2025

Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 10, 2025

Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges - Investing.com Australia

Mar 10, 2025

Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges By Investing.com - Investing.com South Africa

Mar 10, 2025

Rhumbline Advisers Grows Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Mar 10, 2025

Mar 04, 2025

BALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight - GlobeNewswire Inc.

Mar 04, 2025

Tyra Biosciences, Inc. (NASDAQ:TYRA) Sees Large Growth in Short Interest - Defense World

Mar 04, 2025

Mar 03, 2025

Advanced Urothelial Carcinoma Clinical Trial Pipeline - GlobeNewswire

Mar 03, 2025

Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire

Mar 03, 2025

Brokerages Set Tyra Biosciences, Inc. (NASDAQ:TYRA) Price Target at $30.50 - Defense World

Mar 01, 2025

Feb 28, 2025

Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month LowTime to Sell? - MarketBeat

Feb 28, 2025

Feb 27, 2025

Tyra Biosciences stock hits 52-week low at $11.88 amid market shifts - Investing.com Canada

Feb 27, 2025

Feb 20, 2025

(TYRA) Investment Analysis - news.stocktradersdaily.com

Feb 20, 2025

Feb 19, 2025